Two other common cancer genes, TP53 and CDKN2A, were altered in three (10%) and two (7%) cases, respectively, whereas the genes CLPTM1L, SYNE1, CAPN2 and RFPL4A have not been yet implicated in cancer. This evidence concerns the gene CLPTM1L and cancer.